A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients-Reference-Cited by-同舟云学术

A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients

Published:2021-11 Issue: Volume:173 Page:105869
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Wang Ji-Hai,Zeng Zhen,Sun Jie,Chen Yan,Gao Xudong

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Elsevier BV

Subject

Pharmacology

Reference90 articles.

1. STAT3 and its targeting inhibitors in osteosarcoma;Liu;Cell Prolif.,2021

2. Advancing therapy for osteosarcoma;Gill;Nat. Rev. Clin. Oncol.,2021

3. Anti-angiogenic agents in management of sarcoma patients: overview of published trials;Cren;Front. Oncol.,2020

4. Macrophages in osteosarcoma immune microenvironment: implications for immunotherapy;Luo;Front. Oncol.,2020

5. Osteosarcoma-derived small extracellular vesicles enhance tumor metastasis and suppress osteoclastogenesis by miR-146a-5p;Araki;Front. Oncol.,2021

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Antitumor Activity of Herceptin in HER2-Positive Breast Cancer Cells: A Novel DNMT-1 Inhibitor Approach;2024-09-02

2. Prognostic value of genome-wide methylation in acute-on-chronic hepatitis B liver failure;Pathology - Research and Practice;2024-04

3. Novel nanoparticle CS-C60-Fe3O4 magnetically induces tissue-specific aggregation and enhances thermal ablation of hepatocellular carcinoma;Cancer Nanotechnology;2024-01-23

4. Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis;Journal of Cancer;2024

5. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review;Pharmaceutics;2023-12-01